,paragraph,value,label,name,type,company,sent,entity,entity_type_ext,sentence,phrases,qa_temp,key,score,question,answer,GPT3 Responses
0,"The aggregate market value of the voting stock held by nonaffiliates of the Registrant was approximately $152.8 billion at June 30, 2021.",152.8,['Entity Public Float'],dei_EntityPublicFloat,monetaryItemType,hon,"The aggregate market value of the voting stock held by nonaffiliates of the Registrant was approximately $152.8 billion at June 30, 2021.",approximately $152.8 billion,MONEY,"The aggregate market value of the voting stock held by nonaffiliates of the Registrant was approximately $152.8 billion at June 30, 2021.","['aggregate market value of voting stock', 'nonaffiliates of Registrant', 'aggregate market value', 'voting stock']","['aggregate market value of the voting stock', 0.2314014881849289, 'What is approximately $152.8 billion ?', 'aggregate market value of the voting stock']",aggregate market value of the voting stock,0.2314014881849289,What is approximately $152.8 billion ?,aggregate market value of the voting stock,The aggregate market value of the voting stock held by nonaffiliates of the Registrant
1,"There were 685,818,771 shares of Common Stock outstanding at January 28, 2022.","685,818,771","['Entity Common Stock, Shares Outstanding']",dei_EntityCommonStockSharesOutstanding,sharesItemType,hon,"There were 685,818,771 shares of Common Stock outstanding at January 28, 2022.","685,818,771",CARDINAL,"There were 685,818,771 shares of Common Stock outstanding at January 28, 2022.","['shares of Common outstanding Stock', 'Common outstanding Stock']","['shares of Common outstanding Stock', 0.940711259841919, 'how many shares of Common outstanding Stock ?', '685,818,771']",shares of Common outstanding Stock,0.940711259841919,how many shares of Common outstanding Stock ?,"685,818,771",shares of common stock outstanding
2,"See Note 4 Repositioning and Other Charges of Notes to Consolidated Financial Statements for a discussion of our repositioning actions and related charges incurred in 2021, 2020, and 2019. Cash spending related to our repositioning actions was $382 million, $564 million and $249 million in 2021, 2020, and 2019, and was funded through operating cash flows.",382,[],us-gaap_PaymentsForRestructuring,monetaryItemType,hon,"Cash spending related to our repositioning actions was $382 million, $564 million and $249 million in 2021, 2020, and 2019, and was funded through operating cash flows.",$382 million,MONEY,"Cash spending related to our repositioning actions was $382 million, $564 million and $249 million in 2021, 2020, and 2019, and was funded through operating cash flows.","['Cash spending', 'repositioning actions', 'cash flows']","['$564 million', 0.2952297031879425, 'What is $382 million ?', '$564 million']",$564 million,0.2952297031879425,What is $382 million ?,$564 million,Repositioning actions cash spending
3,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,333",['Research and development expense'],us-gaap_ResearchAndDevelopmentExpense,monetaryItemType,hon,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,333 million",MONEY,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.",['Cost of products'],"['Amounts expensed as incurred for Company sponsored research and development projects', 0.3003752827644348, 'What is $1,333 million ?', 'Amounts expensed as incurred for Company sponsored research and development projects']",Amounts expensed as incurred for Company sponsored research and development projects,0.3003752827644348,"What is $1,333 million ?",Amounts expensed as incurred for Company sponsored research and development projects,Company sponsored research and development projects
4,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,334",['Research and development expense'],us-gaap_ResearchAndDevelopmentExpense,monetaryItemType,hon,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,334 million and $1,556 million",MONEY,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.",['Cost of products'],"['research and development projects', 0.29000765085220337, 'What is $1,334 million and $1,556 million ?', 'research and development projects']",research and development projects,0.2900076508522033,"What is $1,334 million and $1,556 million ?",research and development projects,Company sponsored research and development projects
5,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,556",['Research and development expense'],us-gaap_ResearchAndDevelopmentExpense,monetaryItemType,hon,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,334 million and $1,556 million",MONEY,"Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively.",['Cost of products'],"['research and development projects', 0.29000765085220337, 'What is $1,334 million and $1,556 million ?', 'research and development projects']",research and development projects,0.2900076508522033,"What is $1,334 million and $1,556 million ?",research and development projects,Company sponsored research and development projects
6,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,284",['Customer sponsored research and development'],us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned,monetaryItemType,hon,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,284 million",MONEY,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.",[],"['revenue', 0.3517356514930725, 'What is $1,284 million ?', 'revenue']",revenue,0.3517356514930725,"What is $1,284 million ?",revenue,This revenue
7,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,200",['Customer sponsored research and development'],us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned,monetaryItemType,hon,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,200 million",MONEY,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.",[],"['revenue', 0.232127383351326, 'What is $1,200 million ?', 'revenue']",revenue,0.232127383351326,"What is $1,200 million ?",revenue,This revenue
8,"Research and development costs for projects are expensed as incurred, unless these costs relate to contracts with customers where the Company receives reimbursements. Amounts expensed as incurred for Company sponsored research and development projects are included in Cost of products and services sold and were $1,333 million, $1,334 million and $1,556 million for the years ended December 31, 2021, 2020 and 2019, respectively. Costs related to contracts with customers for customer sponsored research and development projects are included as a contract cost and included in Cost of products and services sold when revenue from such contracts is recognized, consistent with the Company's sales recognition policies. This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","1,079",['Customer sponsored research and development'],us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned,monetaryItemType,hon,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.","$1,079 million",MONEY,"This revenue was $1,284 million, $1,200 million and $1,079 million for the years ended December 31, 2021, 2020 and 2019, respectively.",[],"['', 0, '', '']",,0.0,,,"Years ended December 31, 2019"
9,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.",2,['Finite Lived Intangible Assets Estimated Useful Lives'],us-gaap_FiniteLivedIntangibleAssetUsefulLife,durationItemType,hon,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.",2 to 22 years,DATE,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.","['Other intangible assets with determinable lives', 'Other intangible assets', 'determinable lives', 'customer lists', 'useful lives']","['intangible assets', 0.46414485573768616, 'What is 2 to 22 years ?', 'intangible assets']",intangible assets,0.4641448557376861,What is 2 to 22 years ?,intangible assets,Useful life of intangible assets
10,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.",22,['Finite Lived Intangible Assets Estimated Useful Lives'],us-gaap_FiniteLivedIntangibleAssetUsefulLife,durationItemType,hon,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.",2 to 22 years,DATE,"Other intangible assets with determinable lives consist of customer lists, technology, patents and trademarks and other intangibles and are amortized over their estimated useful lives, ranging from 2 to 22 years.","['Other intangible assets with determinable lives', 'Other intangible assets', 'determinable lives', 'customer lists', 'useful lives']","['intangible assets', 0.46414485573768616, 'What is 2 to 22 years ?', 'intangible assets']",intangible assets,0.4641448557376861,What is 2 to 22 years ?,intangible assets,Useful life of intangible assets
11,"The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",1.3,['Capitalized contract fulfillment costs'],us-gaap_CapitalizedContractCostGross,monetaryItemType,hon,"Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020.",approximately $1.3 billion,MONEY,"Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020.",['fulfillment costs'],"['Capitalized contract fulfillment costs', 0.9254520535469055, 'What is approximately $1.3 billion ?', 'Capitalized contract fulfillment costs']",Capitalized contract fulfillment costs,0.9254520535469056,What is approximately $1.3 billion ?,Capitalized contract fulfillment costs,contract fulfillment costs
12,"The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",1.3,['Capitalized contract fulfillment costs'],us-gaap_CapitalizedContractCostGross,monetaryItemType,hon,"Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020.",approximately $1.3 billion,MONEY,"Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020.",['fulfillment costs'],"['Capitalized contract fulfillment costs', 0.9254520535469055, 'What is approximately $1.3 billion ?', 'Capitalized contract fulfillment costs']",Capitalized contract fulfillment costs,0.9254520535469056,What is approximately $1.3 billion ?,Capitalized contract fulfillment costs,contract fulfillment costs
13,"The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",0.1,['Capitalized Contract amounts recognized as Cost of products and services sold'],us-gaap_CapitalizedContractCostAccumulatedAmortization,monetaryItemType,hon,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",approximately $0.1 billion,MONEY,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",['Cost of products'],"['Cost of products and services sold', 0.40111246705055237, 'What is approximately $0.1 billion ?', 'Cost of products and services sold']",Cost of products and services sold,0.4011124670505523,What is approximately $0.1 billion ?,Cost of products and services sold,Cost of products and services sold
14,"The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",0.1,['Capitalized Contract amounts recognized as Cost of products and services sold'],us-gaap_CapitalizedContractCostAccumulatedAmortization,monetaryItemType,hon,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",approximately $0.1 billion,MONEY,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",['Cost of products'],"['Cost of products and services sold', 0.40111246705055237, 'What is approximately $0.1 billion ?', 'Cost of products and services sold']",Cost of products and services sold,0.4011124670505523,What is approximately $0.1 billion ?,Cost of products and services sold,Cost of products and services sold
15,"The customer funding for costs incurred for nonrecurring engineering and development activities of the Company's products under agreements with commercial customers is deferred and subsequently recognized as revenue as products are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funded amount, are deferred as an asset and recognized as cost of sales when products are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on the Company's Consolidated Balance Sheet. Capitalized contract fulfillment costs were approximately $1.3 billion as of December 31, 2021 and 2020. The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",0.1,['Capitalized Contract amounts recognized as Cost of products and services sold'],us-gaap_CapitalizedContractCostAccumulatedAmortization,monetaryItemType,hon,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",approximately $0.1 billion,MONEY,"The amounts recognized as Cost of products and services sold were approximately $0.1 billion for the years ended December 31, 2021, 2020 and 2019.",['Cost of products'],"['Cost of products and services sold', 0.40111246705055237, 'What is approximately $0.1 billion ?', 'Cost of products and services sold']",Cost of products and services sold,0.4011124670505523,What is approximately $0.1 billion ?,Cost of products and services sold,Cost of products and services
16,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",4.2,"['Noncontrolling Interest, Ownership Percentage by Parent']",us-gaap_MinorityInterestOwnershipPercentageByParent,percentItemType,hon,"Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing.",4.2%,PERCENT,"Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing.","['% ownership interest in Cambridge Quantum Computing', '% ownership interest']","['% ownership interest in Cambridge Quantum Computing', 0.8428329825401306, 'what is % ownership interest in Cambridge Quantum Computing ?', '4.2%']",% ownership interest in Cambridge Quantum Computing,0.8428329825401306,what is % ownership interest in Cambridge Quantum Computing ?,4.2%,Honeywell's ownership interest in Cambridge Quantum Computing
17,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",270,['Payments to Acquire Interest in Joint Venture'],us-gaap_PaymentsToAcquireInterestInJointVenture,monetaryItemType,hon,"At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business.",an additional $270 million,MONEY,"At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business.","['closing of business combination', 'controlling majority owner of Quantinuum', 'overall % ownership in business', 'business combination', 'overall % ownership']","['', 0, '', '']",,0.0,,,Honeywell's contribution of cash
18,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",54,['Controlling Interest Ownership Percentage By Parent'],hon_ControllingInterestOwnershipPercentageByParent,percentItemType,hon,"At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business.",54%,PERCENT,"At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business.","['closing of business combination', 'controlling majority owner of Quantinuum', 'overall % ownership in business', 'business combination', 'overall % ownership']","['ownership in the business', 0.2374020516872406, 'What is 54% ?', 'ownership in the business']",ownership in the business,0.2374020516872406,What is 54% ?,ownership in the business,Controlling majority owner
19,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",460,['Non cash adjustment to APIC'],us-gaap_AdjustmentsToAdditionalPaidInCapitalOther,monetaryItemType,hon,"Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum.",$460 million,MONEY,"Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum.","['non cash adjustment', 'contribution of ownership interest', 'ownership interest in Honeywell Quantum Solutions', 'contribution for formation', 'formation of Quantinuum', 'non cash adjustment', 'ownership interest']","['non cash adjustment', 0.666002631187439, 'What is $460 million ?', 'non cash adjustment']",non cash adjustment,0.666002631187439,What is $460 million ?,non cash adjustment,Additional paid in capital
20,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",22,['Fair value adjustment of initial ownership interest in acquired entity'],us-gaap_AssetsFairValueAdjustment,monetaryItemType,hon,"In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations.",$22 million,MONEY,"In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other  expense on in the Consolidated Statement of Operations.","['gain', 'value remeasurement of existing % ownership interest', 'existing % ownership interest in Cambridge Quantum Computing', 'value remeasurement', '% ownership interest', 'Other expense']","['gain', 0.8740037083625793, 'what is gain ?', '$22 million']",gain,0.8740037083625793,what is gain ?,$22 million,Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing
21,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",4.2,"['Noncontrolling Interest, Ownership Percentage by Parent']",us-gaap_MinorityInterestOwnershipPercentageByParent,percentItemType,hon,"Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing.",4.2%,PERCENT,"Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing.","['% ownership interest in Cambridge Quantum Computing', '% ownership interest']","['% ownership interest in Cambridge Quantum Computing', 0.8428329825401306, 'what is % ownership interest in Cambridge Quantum Computing ?', '4.2%']",% ownership interest in Cambridge Quantum Computing,0.8428329825401306,what is % ownership interest in Cambridge Quantum Computing ?,4.2%,Honeywell's ownership interest in Cambridge Quantum Computing
22,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",419,['Noncontrolling interest non cash contribution'],us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue,monetaryItemType,hon,"At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million.",$419 million,MONEY,"At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million.","['close of transaction', 'fair value of noncontrolling interest', 'noncontrolling interest in Quantinuum', 'fair value']","['fair value of noncontrolling interest', 0.9670710563659668, 'what is fair value of noncontrolling interest ?', '$419 million']",fair value of noncontrolling interest,0.9670710563659668,what is fair value of noncontrolling interest ?,$419 million,noncontrolling interest in Quantinuum
23,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",12,['Payments to Acquire Interest in Joint Venture'],us-gaap_PaymentsToAcquireInterestInJointVenture,monetaryItemType,hon,"In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital.",$12 million,MONEY,"In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital.","['cash', 'cash to Quantinuum']","['cash to Quantinuum', 0.972346305847168, 'what is cash to Quantinuum ?', '$12 million']",cash to Quantinuum,0.972346305847168,what is cash to Quantinuum ?,$12 million,Contributing cash to Quantinuum
24,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",90,['Intangible Assets'],us-gaap_IntangibleAssetsCurrent,monetaryItemType,hon,"As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes.",$90 million,MONEY,"As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes.","['assets in Balance Sheet', 'intangible assets', 'tax purposes']","['intangible assets', 0.9685842394828796, 'What is $90 million ?', 'intangible assets']",intangible assets,0.9685842394828796,What is $90 million ?,intangible assets,"Intangible assets

Entity: 
$943 million
Phrase: 
Allocated to goodwill"
25,"On November 29, 2021, Honeywell Quantum Solutions, a wholly owned subsidiary of Honeywell, and Cambridge Quantum Computing, a leading developer of quantum computing and quantum software, combined to form Quantinuum. Prior to closing the transaction, Honeywell held a 4.2% ownership interest in Cambridge Quantum Computing. At closing of the business combination, Honeywell contributed an additional $270 million of cash and is the controlling majority owner of Quantinuum, with an overall 54% ownership in the business. Quantinuum is well positioned to lead the quantum computing industry by offering advanced, fully integrated hardware and software solutions at an unprecedented pace, scale and level of performance to large high growth markets worldwide. Quantinuum supports customer needs for improved computation in cyber security, drug discovery and delivery, material science, finance, and optimization across all major industrial markets. The business is included within Corporate and All Other, which is not considered a reportable business segment. The combination was accounted for under the acquisition method of accounting; as such, assets and liabilities of Quantinuum are consolidated by Honeywell and included in the Consolidated Balance Sheet. Upon close of the transaction, Honeywell recorded a non cash adjustment of $460 million in Additional paid in capital on the Consolidated Balance Sheet as the contribution of ownership interest in Honeywell Quantum Solutions and Cambridge Quantum Computing for the formation of Quantinuum. In addition, Honeywell recognized a gain of $22 million related to the fair value remeasurement of Honeywell's existing 4.2% ownership interest in Cambridge Quantum Computing, which was recorded in Other (income) expense on in the Consolidated Statement of Operations. At close of the transaction, the fair value of Cambridge Quantum Computing's noncontrolling interest in Quantinuum was $419 million. In December 2021, Cambridge Quantum Computing contributed cash of $12 million to Quantinuum, increasing their noncontrolling interest and decreasing Honeywell's additional paid in capital. As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes. The purchase accounting is subject to final adjustments, primarily for the valuation of intangible assets and goodwill.",943,['Goodwill'],us-gaap_Goodwill,monetaryItemType,hon,"As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes.",$943 million,MONEY,"As of December 31, 2021, the assets and liabilities in Honeywell's Consolidated Balance Sheet includes $90 million of intangible assets and $943 million allocated to goodwill, which is non deductible for tax purposes.","['assets in Balance Sheet', 'intangible assets', 'tax purposes']","['goodwill', 0.8458181023597717, 'What is $943 million ?', 'goodwill']",goodwill,0.8458181023597717,What is $943 million ?,goodwill,allocated to goodwill
26,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. Sparta Systems is expected to further strengthen the Company's leadership in industrial automation, digital transformation solutions, and enterprise performance management software. The business is included within the Performance Materials and Technologies segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, tax balances, and certain pre acquisition contingencies.",100,['Controlling Interest Ownership Percentage By Parent'],hon_ControllingInterestOwnershipPercentageByParent,percentItemType,hon,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million.",100%,PERCENT,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million.","['% of outstanding shares', 'leading provider of management software', 'leading provider for sciences industry', 'outstanding shares', 'management software', 'sciences industry']","['% of outstanding shares', 0.9736930727958679, 'what is % of outstanding shares ?', '100%']",% of outstanding shares,0.973693072795868,what is % of outstanding shares ?,100%,The Company acquired the shares outstanding of Sparta Systems.
27,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. Sparta Systems is expected to further strengthen the Company's leadership in industrial automation, digital transformation solutions, and enterprise performance management software. The business is included within the Performance Materials and Technologies segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, tax balances, and certain pre acquisition contingencies.","1,303",['Purchase price'],us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest,monetaryItemType,hon,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million.","$1,303 million",MONEY,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million.","['% of outstanding shares', 'leading provider of management software', 'leading provider for sciences industry', 'outstanding shares', 'management software', 'sciences industry']","['enterprise quality management software for the life sciences industry', 0.20619644224643707, 'What is $1,303 million ?', 'enterprise quality management software for the life sciences industry']",enterprise quality management software for the life sciences industry,0.206196442246437,"What is $1,303 million ?",enterprise quality management software for the life sciences industry,Sparta Systems shares outstanding
28,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. Sparta Systems is expected to further strengthen the Company's leadership in industrial automation, digital transformation solutions, and enterprise performance management software. The business is included within the Performance Materials and Technologies segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, tax balances, and certain pre acquisition contingencies.",383,['Intangible Assets'],us-gaap_IntangibleAssetsCurrent,monetaryItemType,hon,"The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes.",$383 million,MONEY,"The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes.","['intangible assets', 'tax purposes']","['intangible assets', 0.979552686214447, 'What is $383 million ?', 'intangible assets']",intangible assets,0.979552686214447,What is $383 million ?,intangible assets,"intangible assets

Entity: 
$1,011 million
Phrase: 
goodwill"
29,"On February 12, 2021, the Company acquired 100% of the shares outstanding of Sparta Systems, a leading provider of enterprise quality management software for the life sciences industry, for $1,303 million. Sparta Systems is expected to further strengthen the Company's leadership in industrial automation, digital transformation solutions, and enterprise performance management software. The business is included within the Performance Materials and Technologies segment. The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, tax balances, and certain pre acquisition contingencies.","1,011",['Goodwill'],us-gaap_Goodwill,monetaryItemType,hon,"The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes.","$1,011 million",MONEY,"The assets and liabilities acquired with Sparta Systems are included in the Consolidated Balance Sheet as of December 31, 2021, including $383 million of intangible assets and $1,011 million allocated to goodwill, which is nondeductible for tax purposes.","['intangible assets', 'tax purposes']","['goodwill', 0.8475873470306396, 'What is $1,011 million ?', 'goodwill']",goodwill,0.8475873470306396,"What is $1,011 million ?",goodwill,goodwill
30,"During 2020, the Company acquired businesses for an aggregate cost (net of cash and debt assumed) of $261 million, which included the October 2020 acquisition of Rocky Research and the December 2020 acquisition of Sine Group. Rocky Research is a technology leader specializing in thermal, energy and power management solutions and is included within the Aerospace segment. Sine Group offers a Software as a Service (SaaS) that handles visitor management, workplace and supply chain solutions and is included in the Honeywell Building Technologies segment. The acquisition of Rocky Research and Sine Group included approximately $167 million allocated to goodwill, which is non deductible for tax purposes.",261,['Purchase price'],us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest,monetaryItemType,hon,"During 2020, the Company acquired businesses for an aggregate cost (net of cash and debt assumed) of $261 million, which included the October 2020 acquisition of Rocky Research and the December 2020 acquisition of Sine Group.",$261 million,MONEY,"During 2020, the Company acquired businesses for an aggregate cost  of $261 million, which included the October 2020 acquisition of Rocky Research and the December 2020 acquisition of Sine Group.","['aggregate cost', 'acquisition of Rocky Research', 'acquisition of Sine Group', 'aggregate cost']","['aggregate cost', 0.9826442003250122, 'what is aggregate cost ?', '$261 million']",aggregate cost,0.9826442003250122,what is aggregate cost ?,$261 million,Company acquisitions
31,"During 2020, the Company acquired businesses for an aggregate cost (net of cash and debt assumed) of $261 million, which included the October 2020 acquisition of Rocky Research and the December 2020 acquisition of Sine Group. Rocky Research is a technology leader specializing in thermal, energy and power management solutions and is included within the Aerospace segment. Sine Group offers a Software as a Service (SaaS) that handles visitor management, workplace and supply chain solutions and is included in the Honeywell Building Technologies segment. The acquisition of Rocky Research and Sine Group included approximately $167 million allocated to goodwill, which is non deductible for tax purposes.",167,['Goodwill'],us-gaap_Goodwill,monetaryItemType,hon,"The acquisition of Rocky Research and Sine Group included approximately $167 million allocated to goodwill, which is non deductible for tax purposes.",approximately $167 million,MONEY,"The acquisition of Rocky Research and Sine Group included approximately $167 million allocated to goodwill, which is non deductible for tax purposes.","['acquisition of Rocky Research', 'tax purposes']","['goodwill', 0.9695104360580444, 'What is approximately $167 million ?', 'goodwill']",goodwill,0.9695104360580444,What is approximately $167 million ?,goodwill,allocated to goodwill
32,"On March 15, 2021, the Company completed the sale of its retail footwear business in exchange for gross cash consideration of $230 million. The Company recognized a pre tax gain of $95 million for the twelve months ended December 31, 2021, which was recorded in Other (income) expense. The retail footwear business was previously included in the Safety and Productivity Solutions segment.",230,"['Proceeds from sales of businesses, net of fees paid']",us-gaap_ProceedsFromDivestitureOfBusinesses,monetaryItemType,hon,"On March 15, 2021, the Company completed the sale of its retail footwear business in exchange for gross cash consideration of $230 million.",$230 million,MONEY,"On March 15, 2021, the Company completed the sale of its retail footwear business in exchange for gross cash consideration of $230 million.","['sale of retail footwear business', 'sale in exchange', 'exchange for gross cash consideration', 'gross cash consideration', 'retail footwear business', 'gross cash consideration']","['gross cash consideration', 0.9670819640159607, 'what is gross cash consideration ?', '$230 million']",gross cash consideration,0.9670819640159608,what is gross cash consideration ?,$230 million,retail footwear business
33,"On March 15, 2021, the Company completed the sale of its retail footwear business in exchange for gross cash consideration of $230 million. The Company recognized a pre tax gain of $95 million for the twelve months ended December 31, 2021, which was recorded in Other (income) expense. The retail footwear business was previously included in the Safety and Productivity Solutions segment.",95,['Pretax gain on sale'],hon_GainLossOnSaleOfNonstrategicBusinessesAndAssets,monetaryItemType,hon,"The Company recognized a pre tax gain of $95 million for the twelve months ended December 31, 2021, which was recorded in Other (income) expense.",$95 million,MONEY,"The Company recognized a pre tax gain of $95 million for the twelve months ended December 31, 2021, which was recorded in Other  expense.","['pre tax gain', 'pre tax gain', 'Other expense']","['pre tax gain', 0.9731047749519348, 'what is pre tax gain ?', '$95 million']",pre tax gain,0.9731047749519348,what is pre tax gain ?,$95 million,Pre tax gain
34,"The net change in 2021 and 2020 was primarily driven by the receipt of advance payments from customers exceeding recognition of revenue as performance obligations were satisfied prior to billing. For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","1,925",['Contract With Customer Liability Revenue Recognized'],us-gaap_ContractWithCustomerLiabilityRevenueRecognized,monetaryItemType,hon,"For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","$1,925 million",MONEY,"For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","['revenue', 'beginning balance of contract liabilities', 'contract liabilities']","['revenue', 0.5770235061645508, 'what is revenue ?', '$1,925 million']",revenue,0.5770235061645508,what is revenue ?,"$1,925 million",The Company recognized revenue of that was previously included in the beginning balance of contract liabilities.
35,"The net change in 2021 and 2020 was primarily driven by the receipt of advance payments from customers exceeding recognition of revenue as performance obligations were satisfied prior to billing. For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","1,709",['Contract With Customer Liability Revenue Recognized'],us-gaap_ContractWithCustomerLiabilityRevenueRecognized,monetaryItemType,hon,"For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","$1,709 million",MONEY,"For the years ended December 31, 2021 and 2020, the Company recognized revenue of $1,925 million and $1,709 million, respectively, that was previously included in the beginning balance of contract liabilities.","['revenue', 'beginning balance of contract liabilities', 'contract liabilities']","['beginning balance of contract liabilities', 0.9352273941040039, 'what is beginning balance of contract liabilities ?', '$1,709 million']",beginning balance of contract liabilities,0.935227394104004,what is beginning balance of contract liabilities ?,"$1,709 million",The Company's revenue
36,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate.","2,035",['Unbilled Contracts Receivable'],us-gaap_UnbilledContractsReceivable,monetaryItemType,hon,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively.","$2,035 million",MONEY,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively.","['unbilled balances under long term contracts', 'Contract assets', 'unbilled balances', 'long term contracts']","['Contract assets', 0.3134520947933197, 'what is Contract assets ?', '$2,035 million and $1,589 million']",Contract assets,0.3134520947933197,what is Contract assets ?,"$2,035 million and $1,589 million",Contract assets include unbilled balances under long term contracts
37,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate.","1,589",['Unbilled Contracts Receivable'],us-gaap_UnbilledContractsReceivable,monetaryItemType,hon,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively.","$1,589 million",MONEY,"Contract assets include $2,035 million and $1,589 million of unbilled balances under long term contracts as of December 31, 2021 and 2020, respectively.","['unbilled balances under long term contracts', 'Contract assets', 'unbilled balances', 'long term contracts']","['unbilled balances under long term contracts', 0.992199718952179, 'what is unbilled balances under long term contracts ?', '$1,589 million']",unbilled balances under long term contracts,0.992199718952179,what is unbilled balances under long term contracts ?,"$1,589 million",Contract assets under long term contracts
38,"Performance obligations recognized as of December 31, 2021 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",59,"['Revenue, Remaining Performance Obligation, Percentage']",us-gaap_RevenueRemainingPerformanceObligationPercentage,percentItemType,hon,"Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",59%,PERCENT,"Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",['Performance obligations'],"['Performance obligations', 0.9194010496139526, 'What is 59% ?', 'Performance obligations']",Performance obligations,0.9194010496139526,What is 59% ?,Performance obligations,"Performance obligations satisfied within one year

Entity: 
41%
Phrase: 
Performance obligations satisfied greater than one year"
39,"Performance obligations recognized as of December 31, 2021 will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",41,"['Revenue, Remaining Performance Obligation, Percentage']",us-gaap_RevenueRemainingPerformanceObligationPercentage,percentItemType,hon,"Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",41%,PERCENT,"Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively.",['Performance obligations'],"['Performance obligations', 0.9141348004341125, 'What is 41% ?', 'Performance obligations']",Performance obligations,0.9141348004341124,What is 41% ?,Performance obligations,Performance obligations expected to be satisfied within one year
40,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.",331,['Repositioning Charges'],us-gaap_RestructuringCharges,monetaryItemType,hon,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.",$331 million,MONEY,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions in segments', 'severance costs', 'workforce reductions']","['repositioning charges', 0.9300336837768555, 'What is $331 million ?', 'repositioning charges']",repositioning charges,0.9300336837768556,What is $331 million ?,repositioning charges,"Repositioning charges

Entity:
$80 million
Phrase:
Severance costs"
41,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.",80,"['Restructuring and Related Cost, Incurred Cost', 'Total net repositioning charge']",us-gaap_RestructuringAndRelatedCostIncurredCost,monetaryItemType,hon,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.",$80 million,MONEY,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions in segments', 'severance costs', 'workforce reductions']","['severance costs', 0.9925548434257507, 'What is $80 million ?', 'severance costs']",severance costs,0.9925548434257508,What is $80 million ?,severance costs,severance costs related to workforce reductions
42,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.","6,432",['Number Of Employees Severed'],us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated,integerItemType,hon,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.","6,432",CARDINAL,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions in segments', 'severance costs', 'workforce reductions']","['workforce reductions of manufacturing positions', 0.9976966381072998, 'how many workforce reductions of manufacturing positions ?', '6,432']",workforce reductions of manufacturing positions,0.9976966381072998,how many workforce reductions of manufacturing positions ?,"6,432",Manufacturing and administrative positions
43,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.",117,"['Restructuring and Related Cost, Incurred Cost', 'Total net repositioning charge']",us-gaap_RestructuringAndRelatedCostIncurredCost,monetaryItemType,hon,The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment.,$117 million,MONEY,The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment.,"['asset impairments', 'asset impairments', 'certain manufacturing']","['asset impairments', 0.8759666681289673, 'What is $117 million ?', 'asset impairments']",asset impairments,0.8759666681289673,What is $117 million ?,asset impairments,Asset impairments
44,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.",134,"['Restructuring and Related Cost, Incurred Cost', 'Total net repositioning charge']",us-gaap_RestructuringAndRelatedCostIncurredCost,monetaryItemType,hon,"The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment.",$134 million,MONEY,"The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment.","['exit costs', 'lease for equipment', 'exit costs', 'period exit costs', 'repositioning projects', 'site transitions']","['exit costs', 0.9057819843292236, 'what is exit costs ?', '$134 million']",exit costs,0.9057819843292236,what is exit costs ?,$134 million,Exit costs
45,"In 2021, the Company recognized repositioning charges totaling $331 million, including severance costs of $80 million related to workforce reductions of 6,432 manufacturing and administrative positions mainly in the Company's Safety and Productivity Solutions and Aerospace segments. The workforce reductions were primarily related to the re alignment of a product line in the Company's Safety and Productivity Solutions segment, site transitions, mainly in Aerospace, to more cost effective locations, and the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $117 million primarily related to the write down of certain manufacturing and other equipment. The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. Also, $13 million of previously established reserves, primarily for severance, were returned to income due to adjustments to the scope of previously announced repositioning actions.",13,"['Restructuring and Related Cost, Incurred Cost', 'Total net repositioning charge']",us-gaap_RestructuringAndRelatedCostIncurredCost,monetaryItemType,hon,"The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment.",$134 million,MONEY,"The repositioning charge included exit costs of $134 million primarily for current period exit costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment.","['exit costs', 'lease for equipment', 'exit costs', 'period exit costs', 'repositioning projects', 'site transitions']","['exit costs', 0.9057819843292236, 'what is exit costs ?', '$134 million']",exit costs,0.9057819843292236,what is exit costs ?,$134 million,Exit costs
46,"In 2021, Other charges include $105 million of incremental long term contract labor cost inefficiencies due to severe supply chain disruptions (attributable to the COVID 19 pandemic) relating to the warehouse automation business within the Safety and Productivity Solutions segment. Certain of these costs incurred include amounts and provisions for anticipated losses recognized during the fourth quarter when total estimated costs at completion for certain of the business' long term contracts exceeded total estimated revenue. These costs represent unproductive labor costs due to unexpected supply delays and the resulting downstream installation issues, demobilization and remobilization of contract workers, and resolution of contractor disputes. These costs do not include normal operational inefficiencies experienced during a challenging operating environment in 2021.",105,['Other charges'],us-gaap_RestructuringReserveTranslationAndOtherAdjustment,monetaryItemType,hon,"In 2021, Other charges include $105 million of incremental long term contract labor cost inefficiencies due to severe supply chain disruptions (attributable to the COVID 19 pandemic) relating to the warehouse automation business within the Safety and Productivity Solutions segment.",$105 million,MONEY,"In 2021, Other charges include $105 million of incremental long term contract labor cost inefficiencies due to severe supply chain disruptions attributable to the COVID 19 pandemic relating to the warehouse automation business within the Safety and Productivity Solutions segment.","['warehouse automation business within segment', 'Other charges', 'cost inefficiencies', 'severe supply chain attributable disruptions', 'warehouse automation business']","['incremental long term contract labor cost inefficiencies', 0.774638295173645, 'What is $105 million ?', 'incremental long term contract labor cost inefficiencies']",incremental long term contract labor cost inefficiencies,0.774638295173645,What is $105 million ?,incremental long term contract labor cost inefficiencies,Long term contract labor cost inefficiencies
47,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the slowdown in demand for many of its products and services due to the global recession, the Company's productivity and ongoing functional transformation initiatives, and to site consolidations and hub strategies. The repositioning charge included exit costs of $69 million primarily related to current period exit costs incurred for previously approved repositioning projects. Also, $47 million of previously established reserves, primarily for severance, were returned to income mainly as a result of higher attrition than anticipated in prior severance actions resulting in lower payments.",565,['Repositioning Charges'],us-gaap_RestructuringCharges,monetaryItemType,hon,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.",$565 million,MONEY,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions across segments', 'majority of workforce reductions', 'workforce reductions in Materials', 'severance costs', 'workforce reductions', 'workforce reductions']","['repositioning charges', 0.798753559589386, 'What is $565 million ?', 'repositioning charges']",repositioning charges,0.798753559589386,What is $565 million ?,repositioning charges,"Repositioning charges

Entity:
$475 million
Phrase:
Severance costs"
48,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the slowdown in demand for many of its products and services due to the global recession, the Company's productivity and ongoing functional transformation initiatives, and to site consolidations and hub strategies. The repositioning charge included exit costs of $69 million primarily related to current period exit costs incurred for previously approved repositioning projects. Also, $47 million of previously established reserves, primarily for severance, were returned to income mainly as a result of higher attrition than anticipated in prior severance actions resulting in lower payments.",475,"['Restructuring and Related Cost, Incurred Cost', 'Total net repositioning charge']",us-gaap_RestructuringAndRelatedCostIncurredCost,monetaryItemType,hon,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.",$475 million,MONEY,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions across segments', 'majority of workforce reductions', 'workforce reductions in Materials', 'severance costs', 'workforce reductions', 'workforce reductions']","['severance costs', 0.9847099184989929, 'what is severance costs ?', '$475 million']",severance costs,0.9847099184989928,what is severance costs ?,$475 million,Severance costs workforce reductions
49,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies. The workforce reductions primarily related to the Company aligning its cost structure with the slowdown in demand for many of its products and services due to the global recession, the Company's productivity and ongoing functional transformation initiatives, and to site consolidations and hub strategies. The repositioning charge included exit costs of $69 million primarily related to current period exit costs incurred for previously approved repositioning projects. Also, $47 million of previously established reserves, primarily for severance, were returned to income mainly as a result of higher attrition than anticipated in prior severance actions resulting in lower payments.","14,159",['Number Of Employees Severed'],us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated,integerItemType,hon,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.","14,159",CARDINAL,"In 2020, the Company recognized repositioning charges totaling $565 million, including severance costs of $475 million related to workforce reductions of 14,159 manufacturing and administrative positions across the Company's segments, with a majority of the workforce reductions in Aerospace and Performance Materials and Technologies.","['severance costs', 'workforce reductions of manufacturing positions', 'manufacturing positions across segments', 'majority of workforce reductions', 'workforce reductions in Materials', 'severance costs', 'workforce reductions', 'workforce reductions']","['workforce reductions of manufacturing positions', 0.9954996705055237, 'how many workforce reductions of manufacturing positions ?', '14,159']",workforce reductions of manufacturing positions,0.9954996705055236,how many workforce reductions of manufacturing positions ?,"14,159",Workforce reductions
